COR - Cencora, Inc.
NYSE
->
Healthcare
->
Medical Distribution
Conshohocken,
United States
Type: Equity
COR price evolution
COR
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3306.2 | $2068.86 | $2872.35 | $2592.05 |
| Short term investments | ||||
| Net receivables | $24051.48 | $22642.88 | $21576.59 | $20911.08 |
| Inventory | $18301.55 | $17630.99 | $18652.24 | $17454.77 |
| Total current assets | $47307.26 | $44161.05 | $44858.73 | $42798.83 |
| Long term investments | ||||
| Property, plant & equipment | $2080.88 | $2089.5 | $2117.28 | $2135.17 |
| Goodwill & intangible assets | $13624.56 | $13794.61 | $14036.97 | $14005.9 |
| Total noncurrent assets | $19465.16 | $19706.99 | $19831.57 | $19759.92 |
| Total investments | ||||
| Total assets | $66772.42 | $63868.05 | $64690.3 | $62558.75 |
| Current liabilities | ||||
| Accounts payable | $49883.05 | $46320.77 | $47743.47 | $45836.04 |
| Deferred revenue | ||||
| Short long term debt | $565.11 | $1069.15 | $592.78 | $641.34 |
| Total current liabilities | $52973.87 | $49761.81 | $50773.47 | $48831.2 |
| Long term debt | $4165.91 | $4180.31 | $4185.94 | $4146.11 |
| Total noncurrent liabilities | $12738.05 | $12879.21 | $12855.57 | $13061.26 |
| Total debt | $4731.02 | $5249.46 | $4778.72 | $4787.46 |
| Total liabilities | $65711.92 | $62641.02 | $63629.04 | $61892.46 |
| Shareholders' equity | ||||
| Retained earnings | $5514.7 | $5133.77 | $4820 | $4324.19 |
| Other shareholder equity | -$1279.17 | -$1260.29 | -$1136.48 | -$1402.61 |
| Total shareholder equity | $925.21 | $1083.14 | $911.7 | $522 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2592.05 | $3388.19 | $2547.14 | $5.54 |
| Short term investments | ||||
| Net receivables | $20911.08 | $18452.67 | $18167.17 | $20.85 |
| Inventory | $17454.77 | $15556.39 | $15368.35 | $12589.28 |
| Total current assets | $42798.83 | $39589.76 | $38802.61 | $33055.7 |
| Long term investments | ||||
| Property, plant & equipment | $2135.17 | $2135 | $2162.96 | $2003.63 |
| Goodwill & intangible assets | $14005.9 | $12836.62 | $14287.46 | $43.15 |
| Total noncurrent assets | $19759.92 | $16970.86 | $18535.2 | $11219.13 |
| Total investments | ||||
| Total assets | $62558.75 | $56560.62 | $57337.81 | $2176.27 |
| Current liabilities | ||||
| Accounts payable | $45836.04 | $40192.89 | $38009.95 | $79.14 |
| Deferred revenue | ||||
| Short long term debt | $641.34 | $1070.47 | $300.21 | $501.26 |
| Total current liabilities | $48831.2 | $43477.96 | $41358.64 | $33853.08 |
| Long term debt | $4146.11 | $4632.36 | $6383.71 | $1715.91 |
| Total noncurrent liabilities | $13061.26 | $13011.39 | $15394.75 | $11261.39 |
| Total debt | $4787.46 | $5702.83 | $6683.92 | $1715.91 |
| Total liabilities | $61892.46 | $56489.34 | $56753.39 | $2103.8 |
| Shareholders' equity | ||||
| Retained earnings | $4324.19 | $2977.65 | $1670.51 | -$471.91 |
| Other shareholder equity | -$1402.61 | -$1830.97 | -$445.44 | -$20.53 |
| Total shareholder equity | $522 | -$211.56 | $223.35 | $63.58 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $74241.35 | $68414.31 | $72252.83 | $68922.33 |
| Cost of revenue | $71830.58 | $65876.28 | $69784.02 | $66668.88 |
| Gross Profit | $2410.78 | $2538.02 | $2468.81 | $2253.45 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1383.21 | $1388.81 | $1398.75 | $1393.83 |
| Total operating expenses | $1738.3 | $1984.76 | $1645.94 | $1776.51 |
| Operating income | $672.48 | $553.26 | $822.88 | $476.94 |
| Income from continuing operations | ||||
| EBIT | $655.53 | $530.77 | $822.45 | $508.95 |
| Income tax expense | $140.74 | $45.86 | $180.39 | $97.44 |
| Interest expense | $31.33 | $64.13 | $40.56 | $60.94 |
| Net income | ||||
| Net income | $483.46 | $420.77 | $601.5 | $350.56 |
| Income (for common shares) | $483.46 | $420.77 | $601.5 | $350.56 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $262173.41 | $238587.01 | $213988.84 | $606.82 |
| Cost of revenue | $253213.92 | $230290.64 | $207045.61 | $193.85 |
| Gross Profit | $8959.49 | $8296.37 | $6943.23 | $412.97 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $5309.98 | $4848.96 | $3594.25 | $67.75 |
| Total operating expenses | $6618.76 | $5929.99 | $4589.03 | $273.21 |
| Operating income | $2340.73 | $2366.38 | $2354.2 | $139.76 |
| Income from continuing operations | ||||
| EBIT | $2402.48 | $2426.01 | $2391.26 | $124.45 |
| Income tax expense | $428.26 | $516.52 | $677.25 | $0.06 |
| Interest expense | $228.93 | $210.67 | $174.07 | $45.09 |
| Net income | ||||
| Net income | $1745.29 | $1698.82 | $1539.93 | $79.31 |
| Income (for common shares) | $1745.29 | $1698.82 | $1539.93 | $79.31 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $483.46 | $420.77 | $601.5 | $350.56 |
| Operating activities | ||||
| Depreciation | $114.28 | $112.57 | $110.11 | $111.48 |
| Business acquisitions & disposals | -$22.18 | -$2.31 | -$0.15 | |
| Stock-based compensation | $22.18 | $28.16 | $63.08 | $24.93 |
| Total cash flows from operations | $2477.59 | -$878.44 | $885.16 | $1826.81 |
| Investing activities | ||||
| Capital expenditures | -$117.88 | -$112.75 | -$74.22 | -$175.5 |
| Investments | -$6.96 | -$58.02 | -$6.25 | |
| Total cash flows from investing | -$143.92 | -$166.49 | -$65.8 | -$183.44 |
| Financing activities | ||||
| Dividends paid | -$102.53 | -$107 | -$105.69 | -$98.34 |
| Sale and purchase of stock | -$537.08 | -$43.14 | -$374.61 | -$262.44 |
| Net borrowings | -$504.33 | $482.88 | -$10.47 | -$41.7 |
| Total cash flows from financing | -$1145.23 | $323.17 | -$551.67 | -$407.01 |
| Effect of exchange rate | $2.82 | -$29.21 | $15.54 | -$31.72 |
| Change in cash and equivalents | $1191.25 | -$750.98 | $283.23 | $1204.64 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1745.29 | $1698.82 | $1539.93 | $79.31 |
| Operating activities | ||||
| Depreciation | $418.83 | $390.64 | $326.71 | $168.91 |
| Business acquisitions & disposals | -$1409.84 | $138.77 | -$5563.04 | |
| Stock-based compensation | $124.62 | $93.4 | $99.59 | $15.84 |
| Total cash flows from operations | $3911.33 | $2703.09 | $2666.59 | $271.08 |
| Investing activities | ||||
| Capital expenditures | -$458.36 | -$490.02 | -$423.78 | -$267.65 |
| Investments | -$743.27 | -$18.49 | -$162.62 | |
| Total cash flows from investing | -$2602.47 | -$368.44 | -$6141.58 | -$267.65 |
| Financing activities | ||||
| Dividends paid | -$398.75 | -$391.69 | -$366.65 | -$236.3 |
| Sale and purchase of stock | -$1119.58 | -$389.79 | $116.6 | $0.48 |
| Net borrowings | -$623.26 | -$923.1 | $2216.55 | $236 |
| Total cash flows from financing | -$2222.28 | -$1752.78 | $1952.85 | -$0.93 |
| Effect of exchange rate | $72.76 | -$57.85 | -$3.73 | |
| Change in cash and equivalents | -$840.65 | $523.41 | -$1527.62 | $2.5 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $283.83B |
|---|---|
| EBITDA | $2.97B |
| EBIT | $2.52B |
| Net Income | $1.86B |
| Revenue Q/Q | 10.90% |
| Revenue Y/Y | 11.56% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 2.88% |
| ROE | 215.72% |
| Debt/Equity | 118.57 |
|---|---|
| Net debt/EBITDA | 21.04 |
| Current ratio | 0.89 |
| Quick ratio | 0.55 |